Finally! More Accurate, Comfortable &
Reimbursable Nasal Sampling
The nasopharyngeal swab collection method for respiratory infection nasal sampling is invasive, painful and prone to collection errors. Patients cringe at the thought of a swab, contributing to hesitation that leads to poor specimen collection or testing avoidance altogether — which puts public health at risk.
MicroWash replaces swab collection, delivering a pleasant experience for patients and a more reliable specimen for medical professionals. It’s not just welcome news to anyone who’s had a swab rammed up their nose ― the patented MicroWash device delivers higher-sensitivity samples, has a longer shelf life and makes sample collection reimbursable, unlike swab collection.
Discover the MicroWash Difference
Data has shown MicroWash to be the superior nasal specimen sampling solution.
MicroWash Sample Collection Reimbursement
University Medical Devices (UMD) and UMD’s sales partner, Virology Testing Products (VTP), along with AAPC, a highly regarded national reimbursement coding consulting firm, have identified CPT code for MicroWash sample collection that are reimbursed by both Medicare and most private insurance payers. This, coupled with the significant MicroWash sample URI pathogen PCR sensitivity, builds a compelling, multifactorial case for its use in lieu of standard nasal swab sampling. For more information, please eMail Virology Testing Products (VTP) at osborn.jim@vtpmedical.com or call (913) 226-6628.
Discover More Advantages
Healthcare providers and labs benefit from higher-sensitivity specimens with a device that seamlessly
fits into current lab processing procedures, enabling rapid diagnosis and treatment decisions.
Healthcare providers and labs benefit from higher-quality specimens with a device that seamlessly fits into current lab processing procedures, enabling rapid diagnosis and treatment decisions.
